VivoSeq
Other

Echocardiography

0

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

Echocardiography is an early-stage landscape with 0 programs across 1 company. The most active players are Gilead.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

20/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Gilead logo

Gilead

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed10 · 67%
Unknown status2 · 13%
Terminated2 · 13%
Withdrawn1 · 7%

Clinical Trials

Trial Activity

15 trials

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)
Completed·TThe Cleveland Clinic·Phase 4·NCT00289042·200 enrolled
Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI
Completed·NNanjing First Hospital, Nanjing Medical University·N/A·NCT05682716·137 enrolled
Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy
Completed·MMayo Clinic·Phase 4·NCT02880137·36 enrolled
Dexmedetomidine in Children Having Transthoracic Echocardiography
Completed·—·Phase 4·NCT02523144·279 enrolled
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Completed·LLantheus Medical Imaging·Phase 4·NCT00401687·131 enrolled
Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis
Completed·UUniversity of Chicago·Phase 4·NCT02754518·40 enrolled
Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study
Completed·AAcusphere·Phase 3·NCT00669851·39 enrolled
A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography
Completed·TTrust Bio-sonics, Inc.·Phase 1/2·NCT04185246·36 enrolled
The Primary Objective of This Study Was to Investigate the Effect of Insulin on Myocardial Perfusion and Cardiac Function in Patients Undergoing Cardiac Surgery for CPB Using Transesophageal Echocardiography (TEE) to Detect CSBF
Completed·YYangzhou University·N/A·NCT05464966·74 enrolled
Short- and Medium-term Outcomes of New Generation Biological Aortic Valves in Aortic Valve Replacement Surgery
Completed·CCentre Hospitalier Universitaire, Amiens·N/A·NCT05055089·172 enrolled
Stress Echocardiography Study With Regadenoson
Terminated·Gilead logoGilead·Phase 2·NCT00907764·22 enrolled
Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems
Terminated·PPoint Biomedical·Phase 2·NCT00487903·40 enrolled
Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)
Withdrawn·UUniversity Hospital, Basel, Switzerland·Phase 1/2·NCT00286559
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
Unknown status·OOregon Health and Science University·N/A·NCT02560467·10 enrolled
Echocardiography During Ajmaline Test
Unknown status·UUniversitair Ziekenhuis Brussel·N/A·NCT03491475·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)